Cargando…

Comprehensive Analysis of Cellular Senescence-Related Genes in Prognosis, Molecular Characterization and Immunotherapy of Hepatocellular Carcinoma

BACKGROUND: Cellular senescence is a tumor suppressive response in which the cell cycle is in a state of permanent arrest and can inhibit tumor cell proliferation. In recent years, induction of cellular senescence has been shown to be important for antitumor therapy, and the link between cellular se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Liang, Liu, Zitao, Ning, Ke, Wu, Zhipeng, Chen, Zhendong, Wu, Zhengyi, Yin, Xiangbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761989/ https://www.ncbi.nlm.nih.gov/pubmed/36536279 http://dx.doi.org/10.1186/s12575-022-00187-7

Ejemplares similares

Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma
por: Yuan, Weiwei, et al.
Publicado: (2023)

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma
por: Tang, Yuqin, et al.
Publicado: (2022)

Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma
por: Lu, Caibao, et al.
Publicado: (2022)

Pancancer analysis of oncogenic BARX2 identifying its prognostic value and immunological function in liver hepatocellular carcinoma
por: Yu, Shian, et al.
Publicado: (2023)

Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
por: Mittermeier, Constanze, et al.
Publicado: (2020)

Prognosis signature for predicting the survival and immunotherapy response in esophageal carcinoma based on cellular senescence-related genes
por: Wang, Yue, et al.
Publicado: (2023)

Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
por: Yu, Xue, et al.
Publicado: (2022)

Comprehensive Analysis of RAPGEF2 for Predicting Prognosis and Immunotherapy Response in Patients with Hepatocellular Carcinoma
por: Wu, Qing, et al.
Publicado: (2022)

Comprehensive analysis for cellular senescence-related immunogenic characteristics and immunotherapy prediction of acute myeloid leukemia
por: Mao, Yan, et al.
Publicado: (2022)

Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2023)

Comprehensive analysis of anoikis‐related lncRNAs for predicting prognosis and response of immunotherapy in hepatocellular carcinoma
por: Du, Sihao, et al.
Publicado: (2023)

Cellular senescence and lung cancer prognosis
por: Asaithamby, Aroumougame, et al.
Publicado: (2022)

Cellular senescence‐related long noncoding ribonucleic acids: Predicting prognosis in hepatocellular carcinoma
por: Huang, Hao, et al.
Publicado: (2023)

Cellular senescence-related gene signature as a valuable predictor of prognosis in hepatocellular carcinoma
por: Zhang, Shuqiao, et al.
Publicado: (2023)

Identification of a novel cellular senescence-related signature for the prediction of prognosis and immunotherapy response in colon cancer
por: Dai, Longfei, et al.
Publicado: (2022)

Comprehensive assessment of cellular senescence in the tumor microenvironment
por: Wang, Xiaoman, et al.
Publicado: (2022)

A predictive molecular signature consisting of lncRNAs associated with cellular senescence for the prognosis of lung adenocarcinoma
por: Liu, Anbang, et al.
Publicado: (2023)

Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
por: Cai, Xiurong, et al.
Publicado: (2022)

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study
por: Liu, Tingjun, et al.
Publicado: (2023)

A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma
por: Luo, Yi, et al.
Publicado: (2022)

TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma
por: Li, Yong, et al.
Publicado: (2022)

Comprehensive molecular and immunological characterization of hepatocellular carcinoma
por: Shimada, Shu, et al.
Publicado: (2018)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022)

Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas
por: Zhou, Zijian, et al.
Publicado: (2022)

Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas
por: Han, Mingzhi, et al.
Publicado: (2022)

A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification
por: Li, Jiaming, et al.
Publicado: (2023)

A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity
por: Shao, Huijing, et al.
Publicado: (2023)

A Cellular Senescence-Related Signature Predicts Cervical Cancer Patient Outcome and Immunotherapy Sensitivity
por: Shao, Huijing, et al.
Publicado: (2023)

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
por: Hendrickson, Peter G., et al.
Publicado: (2019)

Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer
por: Dai, Longfei, et al.
Publicado: (2022)

Comprehensive Molecular and Cellular Characterization of Acute Kidney Injury Progression to Renal Fibrosis
por: Wu, Renyan, et al.
Publicado: (2021)

LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1/M2 polarization of Kupffer cells
por: Wu, Huajun, et al.
Publicado: (2020)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

Microenvironment characterization and multi-omics signatures related to prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Furong, et al.
Publicado: (2020)

Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma
por: Hu, Jian, et al.
Publicado: (2022)

Identification and characterization of a novel molecular classification based on disulfidptosis-related genes to predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Yang, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d16jpdh9m2922rvh019rj8iu79